Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
307
-
Total 13F shares, excl. options
-
36.8M
-
Shares change
-
+514K
-
Total reported value, excl. options
-
$2.3B
-
Value change
-
-$367M
-
Put/Call ratio
-
1.28
-
Number of buys
-
181
-
Number of sells
-
-203
-
Price
-
$62.35
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q4 2024
454 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q4 2024.
TransMedics Group, Inc. - Common Stock (TMDX) has 307 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.8M shares
.
Largest 10 shareholders include BlackRock, Inc. (5.23M shares), FMR LLC (4.01M shares), VANGUARD GROUP INC (3.64M shares), STATE STREET CORP (1.36M shares), FIL Ltd (1M shares), MACQUARIE GROUP LTD (993K shares), BRAIDWELL LP (922K shares), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (903K shares), MACKENZIE FINANCIAL CORP (828K shares), and GEODE CAPITAL MANAGEMENT, LLC (773K shares).
This table shows the top 307 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.